Breast cancer is the most common malignancy among women and the contribution of hereditary susceptibility to its development has been well recognized. However, the known genetic risk factors still ...
Join us for an installment of our Bionano In Motion webinar series as our speakers delve into immunotherapies and the emerging role of optical genome mapping (OGM) in assessing genome integrity as ...
Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in The ...
Cancer genomics, a young and evolving field, seeks to comprehensively examine all gene alterations and expression differences across the entire genetic landscape. With their increasing sophistication, ...
Genomic testing based on chromosome microarray (CMA) and Next Generation Sequencing (NGS) revolutionized clinical genetics. That said, microarray, targeted panel, exome and generic whole genome ...
Bionano Genomics, Inc. announced a groundbreaking study published in Modern Pathology, which highlights the effectiveness of optical genome mapping (OGM) in detecting bone and soft tissue tumors. This ...
SAN DIEGO, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 2 of Bionano Symposium 2026, which focused on New Frontiers in Oncology and ...
Bionano will preview the solution with NVIDIA at the Advances in Genome Biology and Technology (AGBT) General Meeting, which will take place February 6-9, 2023, in Hollywood, Florida. “Bionano is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results